Anal fistula
Conditions
Interventions
Experimental group:External Use of Yuyangfang
Control group:External Use of Kangfu New Liquid
Sponsors
Nanjing Hospital OF C.M
Eligibility
Sex/Gender
All
Age
18 Years to 75 Years
Inclusion criteria
Inclusion criteria: (1) Age 18-75 years, male or female; (2) Meets the Western medical diagnostic criteria for postoperative anal fistula wounds; (3) Meets the traditional Chinese medicine diagnostic criteria, with TCM pattern differentiation of blood stasis and damp-heat type; (4) Agrees to participate in this trial and voluntarily signs the informed consent form;
Exclusion criteria
Exclusion criteria: (1) Women who are pregnant, planning pregnancy, or breastfeeding; (2) Individuals with severe anemia (Hb < 60 g/L); (3) Those with severe intestinal complications (such as intestinal perforation, intestinal obstruction, toxic megacolon, colorectal cancer); (4) Individuals with allergic constitution or known allergies to the drugs to be used in this trial; (5) Patients with serious primary diseases of the liver, kidney, hematopoietic system, or psychiatric disorders; (6) Patients who have participated in other drug clinical trials within the past 4 weeks; (7) Patients with proctitis, rectal stenosis, or even obstruction, severe bleeding, or fistula formation requiring surgical treatment;
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Overall efficacy; | — |
Secondary
| Measure | Time frame |
|---|---|
| Pain;Granulation condition;Secretion condition;Healing time;Relapse;Anal function; | — |
Countries
China
Contacts
Public ContactDINGKANG
Nanjing Hospital OF C.M
Outcome results
None listed